Dr. Michael Zurenko, MD, Radiation ...

Dr. Michael D. Zurenko

Claim this profile

Prisma Health Cancer Institute - Eastside

Studies Prostate Cancer
Studies Small Cell Lung Cancer
8 reported clinical trials
16 drugs studied

Affiliated Hospitals

Image of trial facility.
Prisma Health Cancer Institute - Eastside
Image of trial facility.
Prisma Health Cancer Institute - Faris

Clinical Trials Michael D. Zurenko is currently running

Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Image of trial facility.

Radiation Therapy vs Observation

for Meningioma

This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.
Recruiting2 awards Phase 312 criteria

More about Michael D. Zurenko

Clinical Trial Related9 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Michael D. Zurenko has experience with
  • Radiation Therapy
  • Intensity-Modulated Radiation Therapy
  • Atezolizumab
  • Cisplatin
  • Clinical Observation
  • Intensity-Modulated Radiation Therapy (IMRT)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Michael D. Zurenko specialize in?
Is Michael D. Zurenko currently recruiting for clinical trials?
Are there any treatments that Michael D. Zurenko has studied deeply?
What is the best way to schedule an appointment with Michael D. Zurenko?
What is the office address of Michael D. Zurenko?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security